Trial Profile
Effect of ivabradine and ranolazine when given in combination with standard therapy in patients with chronic stable angina pectoris
Status:
Completed
Phase of Trial:
Phase III
Latest Information Update: 21 Mar 2015
Price :
$35
*
At a glance
- Drugs Ivabradine (Primary) ; Ranolazine (Primary)
- Indications Angina pectoris
- Focus Therapeutic Use
- 21 Mar 2015 New trial record